Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis
Author:
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (11) , 1837-1852
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuationAnnals of the Rheumatic Diseases, 1997
- Special article the economic cost and social and psychological impact of musculoskeletal conditionsArthritis & Rheumatism, 1995
- Management of Adverse Effects of Disease-Modifying Antirheumatic DrugsDrug Safety, 1995
- Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritisInflammation Research, 1990
- Development of Auto immunity in MRL/Ipr Mice and the Effects of Drugs on this Murine DiseaseScandinavian Journal of Rheumatology, 1988
- The use of the murine chronic graft Vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discoveryInflammation Research, 1987
- Disease modifying activity of HWA 486 in rat adjuvant-induced arthritisInflammation Research, 1987
- Cyclosporin A inhibits autoimmune experimental tubulointerstitial nephritisImmunology Letters, 1987
- Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the ratInternational Journal of Immunopharmacology, 1985
- Experimental Allergic Encephalomyelitis in the Rat: Response to Encephalitogenic Proteins and PeptidesScience, 1973